Prix Galien Russia Officially Launched
Moscow, February 18th 2012 - A VIP cocktail reception announcing the first Prix Galien Russia was hosted by Monsieur Jean de Gliniasty, Ambassador of France to the Russian Federation and Frédéric Boucheseiche, General Secretary of the Prix Galien Russia. The reception was held on February 7 at the Igumnov House – which was built in 1883 – 1893 to the design by Nikolay Pozdeyev , residence of the French Ambassadors to Russia since 1979.
This reception marked the official launch of the Prix Galien Russia, which is set to quickly become the highlight of the year underscoring innovation in the pharmaceutical industry in Russia.
Globally, the Galien Award is the most coveted award for the pharmaceutical industry and often regarded as the Nobel Prize for innovation in life sciences and biopharmaceutical research. Founded over 40 years ago in France, there are now 16 countries organizing a national Galien Prize. Russia is the latest country to join the list of organizing nations. Every two years, laureate recipients of national awards compete in a global competition, The Prix Galien International.
The event was attended by over 60 VIP guests including academicians and eminent scientists, decision makers of the pharmaceutical industry.
After an introductory speech by the Ambassador and the General Secretary, the selection committee was unveiled:
Prof. Alexander Grigorievich Chuchalin (Chairman of the committee)
Prof. Vladimir Trofimovich Ivashkin
Prof. Eugeny Lvovich Nasonov
Prof. Rem Viktorovich Petrov
Prof. Dmitry Yurievich Pushkar
Prof. GennadyTikhonovich Sukhikh
Prof. Evgeny Davidovich Sverdlov
Prof. Vsevolod Arsenievich Tkachuk
Prof. Michael Veniaminovich Ugrumov (Vice Chairman of the committee)
The selection committee is completely independent in the judging process and its decisions are final. The Jury will select finalists in the following categories: Best Pharmaceutical Agent (i.e. small molecule), Best Biotechnology Product and Best Medical Technology.
The prizes will be awarded principally based on two criteria:
- What was innovative in the course of this product’s scientific development, application or clinical utility?
- What was learned for the future of biomedical science from this product’s introduction to the clinic?
Criteria that will NOT be considered are the size of the market, the size of the company, the cost of development or the contingencies of distribution.
In addition, a special Prize named the “Prix Galien Russia – Research” will be awarded to the researcher or the research team judged by the Selection Committee to have made the most significant contribution to bio-pharmaceutical research in Russia.
The winners of each category will receive the prestigious commemorative Prix Galien Medal in a gala dinner and awards ceremony in Moscow on October 24th, 2013. Over 200 guests, including many academic, industry and government luminaries are expected to attend.
For more information about the Prix Galien Russia 2013 you can log on www.prixgalienrussia.com or contact firstname.lastname@example.org .